by Nathaniel Harding | Feb 12, 2024 | Media
Our Principal, Susan Moring, joined CorriXR CEO, Deborah Moorad and CorriXR’s Founder and CSO, Eric B. Kmiec, in an exclusive interview with OETA. This insightful interview highlights the pioneering efforts this amazing company is making in transforming gene editing...
by Nathaniel Harding | Feb 7, 2024 | Media
We are excited to share an exclusive feature published by Axios on Lumata Health on their Series A+ funding round from 2023. We are proud to have one of our spectacular portfolio companies featured in such a reputable publication, and we look forward to continued...
by Nathaniel Harding | Feb 7, 2024 | Media
This article discusses the impact of the Federal Reserve’s decision not to cut interest rates and its implications for various sectors, including venture capital (VC). The Federal Reserve’s indication that rate cuts are unlikely in the near future has led...
by Nathaniel Harding | Feb 1, 2024 | Blog
2023 Lookback for Cortado Ventures — Read the full story here At Cortado Ventures, we’re excited for 2024. In our company meeting this week, we strategized our position in the Midcontinent market and what it will take to source, select, and support the best and...
by Nathaniel Harding | Jan 23, 2024 | Newsletters
Bottom Line Up Front (BLUF) In this month’s Doubleshot Newsletter, you will find: Message from our Managing Partner Annual General Meeting 2023 Investment News: CorriXR Portco News: Glycologix Midcon Markup Podcast: New Episode with Blake Bixler Portco Job...
